Vladlen G. Klochkov
Volgograd, VGG 400131, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
3-Arylidene-2-oxindoles as GSK3β inhibitors and anti-thrombotic agents.
Journal: Bioorganic & medicinal chemistry letters
Published: January 28, 2023
3-Arylidene-2-oxindoles as Potent NRH:Quinone Oxidoreductase 2 Inhibitors.
Journal: Molecules (Basel, Switzerland)
Published: December 09, 2022
Amino Derivatives of Diaryl Pyrimidines and Azolopyrimidines as Protective Agents against LPS-Induced Acute Lung Injury.
Journal: Molecules (Basel, Switzerland)
Published: December 06, 2022
Guanidine Derivatives of Quinazoline-2,4(1H,3H)-Dione as NHE-1 Inhibitors and Anti-Inflammatory Agents.
Journal: Life (Basel, Switzerland)
Published: September 21, 2022
Design, Synthesis and Pharmacological Evaluation of Novel C2,C3-Quinoxaline Derivatives as Promising Anxiolytic Agents.
Journal: International journal of molecular sciences
Published: August 30, 2022
Discovery of Nitro-azolo[1,5-a]pyrimidines with Anti-Inflammatory and Protective Activity against LPS-Induced Acute Lung Injury.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 18, 2022
Synthesis and multifaceted pharmacological activity of novel quinazoline NHE-1 inhibitors.
Journal: Scientific reports
Published: September 04, 2021
Towards multi-target antidiabetic agents: In vitro and in vivo evaluation of 3,5-disubstituted indolin-2-one derivatives as novel α-glucosidase inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: July 13, 2021
Neural network modeling of multitarget RAGE inhibitory activity
Journal: Biomeditsinskaia khimiia
Published: April 06, 2019
Synthesis, in vitro and in vivo evaluation of 2-aryl-4H-chromene and 3-aryl-1H-benzo[f]chromene derivatives as novel α-glucosidase inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: September 11, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026